Elon Musk’s high-profile lawsuit against OpenAI is set for a jury trial in spring 2026, as ruled by Judge Yvonne Gonzalez Rogers of the U.S. District Court for the Northern District of California. The case centers on Musk’s claims that OpenAI and CEO Sam Altman strayed from the company’s original nonprofit mission to develop artificial intelligence for the benefit of humanity, not corporate gain.
Musk co-founded OpenAI with Altman in 2015 but exited before its rapid growth and later founded rival AI startup xAI in 2023. Last month, xAI acquired Musk’s social media platform X, in a deal valuing the platform at $33 billion, further intertwining Musk’s AI ambitions with his existing ventures.
The court denied Musk’s request to halt OpenAI’s transition to a for-profit model but agreed to expedite the trial. OpenAI and Altman maintain that the shift to a for-profit structure is essential to secure large-scale funding and remain competitive in the costly AI industry. They argue that Musk’s lawsuit is an attempt to undermine a key competitor.
OpenAI is under financial pressure as it seeks to raise up to $40 billion in new funding, led by Japan’s SoftBank. The tech investment group has reportedly committed $10 billion by mid-April and an additional $30 billion by December, contingent upon OpenAI completing its for-profit transition by year-end.
Earlier this year, Altman rejected a $97.4 billion unsolicited takeover bid from a Musk-led consortium, reaffirming that OpenAI is not for sale. With the trial now on the horizon, the legal battle between Musk and OpenAI marks a pivotal moment in the broader race for AI dominance.


Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Federal Judge Restores Funding for Gateway Rail Tunnel Project
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



